Opposition
Defendant |
Name: | Actavis, Inc. |
Correspondence: | GABRIELLE S ROTH SUGHRUE MION PLLC 2100 PENNSYLVANIA AVE NW WASHINGTON, DC 20037-3213 UNITED STATES groth@sughrue.com, tm@sughrue.com, kdunmire@sughrue.com Phone: 202-293-7060 |
|
Applications/registrations |
|
Serial #: | 85830300 | Application File | Assignment | | |
Application Status: | ABANDONED - NO STATEMENT OF USE FILED |
Mark: | ACTAVIS PHARMA |
Plaintiff |
Name: | Genentech, Inc. |
Correspondence: | HAROLD MILSTEIN SHEPPARD MULLIN RICHTER & HAMPTON LLP 379 LYTTON AVENUE PALO ALTO, CA 94301 UNITED STATES svtmdocketing@sheppardmullin.com, cbush@sheppardmullin.com, hmilstein@sheppardmullin.com Phone: 650-815-2600 |
|
Pleaded applications and registrations |
|
Serial #: | 73534873 | Application File | Assignment | Registration #: | 1398216 |
Application Status: | REGISTERED AND RENEWED |
Mark: | ACTIVASE |
|
|
Serial #: | 78546712 | Application File | Assignment | Registration #: | 3613829 |
Application Status: | CANCELLED - SECTION 8 |
Mark: | ACTIVASE ALTEPLASE A RECOMBINANT TISSUEPLASMINOGEN ACTIVATOR THE ONE T-PA FOR STROKE |
|
|
Serial #: | 78546717 | Application File | Assignment | Registration #: | 3584619 |
Application Status: | CANCELLED - SECTION 8 |
Mark: | CATHFLO ACTIVASE (ALTEPLASE) THE ONE 2-MG T-PA |
|
|